Advertisement
UK markets close in 5 hours 44 minutes

  • FTSE 100

    8,088.51
    +48.13 (+0.60%)
     

  • FTSE 250

    19,729.59
    +10.22 (+0.05%)
     

  • AIM

    755.15
    +0.46 (+0.06%)
     

  • GBP/EUR

    1.1669
    +0.0024 (+0.21%)
     

  • GBP/USD

    1.2520
    +0.0058 (+0.46%)
     

  • Bitcoin GBP

    51,038.56
    -1,957.52 (-3.69%)
     

  • CMC Crypto 200

    1,363.60
    -18.98 (-1.37%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    82.73
    -0.08 (-0.10%)
     

  • GOLD FUTURES

    2,337.30
    -1.10 (-0.05%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,981.43
    -107.27 (-0.59%)
     

  • CAC 40

    8,049.24
    -42.62 (-0.53%)
     
Property:

How to sell your home

Top tips from property investors

4 big analyst picks: Rambus stock surges on Jefferies upgrade

Investing.com
·2-min read

Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades for Rambus, WEC Energy, Dynatrace, and Teva Pharma.

InvestingPro subscribers got this news before anyone else. Start your 7-day trial to get on board.

Rambus shares soar on Jefferies upgrade

Rambus (NASDAQ:RMBS) shares surged more than 9% yesterday after Jefferies upgraded the company to Buy from Hold and raised its price target to $65.00 from $45.00, as reported in real time on InvestingPro.

The upgrade followed recent meetings with management and increased confidence in the company’s positioning. According to Jefferies, the company is well positioned for not only leading buffer chip share in ramping DDR5 but also for a meaningful share in the significant adjacent growth opportunities of companion chips and CXL.

ADVERTISEMENT

Earlier this month, the company reported its Q1 earnings, significantly missing the Street estimates.

WEC Energy upgraded to Buy at Mizuho

Mizuho Securities upgraded WEC Energy (NYSE:WEC) to Buy from Neutral with a price target of $98.00.

According to the firm, regulatory concerns that resulted in a stock underperformance over the past two months are overblown given WEC largely resolved its WI filings earlier this year, covering the WI utilities through 2024. Furthermore, on the IL side, the firm noted that the staff testimony published earlier this month appears constructive.

2 more upgrades

BTIG upgraded Dynatrace (NYSE:DT) to Buy from Neutral with a price target of $57.00 following the Q4 beat on Wednesday, highlighted by upside on all key metrics.

According to BTIG, growth appears to be stabilizing despite macro headwinds and ongoing customer cloud optimization initiatives. Furthermore, the firm noted that commentary on new products, namely application security and log monitoring, was encouraging.

Evercore ISI upgraded Teva Pharma (NYSE:TEVA) to Outperform from In Line following the company's reported Q1 results last week, with revenue coming in better than expected, while EPS missing the estimates.

In fast-moving markets, every second counts - and InvestingPro subscribers are always one step ahead with lightning-quick updates.

Start your free 7-day trial now.

Related Articles

4 big analyst picks: Rambus stock surges on Jefferies upgrade

Catalent cuts annual revenue forecast hurt by operational challenges

Deere raises annual profit outlook on healthy equipment demand, strong order books